79). Evidence supporting this mechanism has accumulated from studies in human tumour xenograft models of pancreatic and colorectal cancers that express high levels of HH ligands, in which increased expression of HH targets is detected specifically in tumour-infiltrating mouse stromal cells (Ref. 79). Interestingly, growth of mutant Kras-driven tumours is reduced in mice lacking Gli1 in the pancreatic microenvironment compared to wild-type mice (Ref. 80). The gene discussed is GLI1; the disease is neoplasm.